These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 1791538

  • 1. Tissue levels and some pharmacological properties of an acetylated metabolite of phenelzine in the rat.
    Coutts RT, Mozayani A, Danielson TJ, Baker GB.
    J Pharm Sci; 1991 Aug; 80(8):765-7. PubMed ID: 1791538
    [Abstract] [Full Text] [Related]

  • 2. N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.
    McKenna KF, Baker GB, Coutts RT.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):478-82. PubMed ID: 1881457
    [Abstract] [Full Text] [Related]

  • 3. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF, Baker GB, Coutts RT, Greenshaw AJ.
    J Pharm Sci; 1992 Aug; 81(8):832-5. PubMed ID: 1383493
    [Abstract] [Full Text] [Related]

  • 4. Metabolic acetylation of phenelzine in rats.
    Mozayani A, Coutts RT, Danielson TJ, Baker GB.
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):397-406. PubMed ID: 3222522
    [Abstract] [Full Text] [Related]

  • 5. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
    McKenna KF, Baker GB, Coutts RT, Rauw G, Mozayani A, Danielson TJ.
    J Neural Transm Suppl; 1990 Dec; 32():113-8. PubMed ID: 1982447
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The antidepressant drug phenelzine produces antianxiety effects in the plus-maze and increases in rat brain GABA.
    Paslawski T, Treit D, Baker GB, George M, Coutts RT.
    Psychopharmacology (Berl); 1996 Sep; 127(1):19-24. PubMed ID: 8880939
    [Abstract] [Full Text] [Related]

  • 8. Stress reduces in vivo inhibition of monoamine oxidase by phenelzine in rat brain.
    Clow A, Glover V, Oxenkrug GF, Sandler M.
    Neurosci Lett; 1989 Dec 15; 107(1-3):331-4. PubMed ID: 2616044
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic deuterated and non-deuterated phenelzine on rat brain monoamines and monoamine oxidase.
    Dyck LE, Juorio AV, Durden DA, Boulton AA.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Mar 15; 337(3):279-83. PubMed ID: 3393230
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and specificity of phenelzine and benserazide as inhibitors of benzylamine oxidase and monoamine oxidase.
    Andree TH, Clarke DE.
    Biochem Pharmacol; 1982 Mar 01; 31(5):825-30. PubMed ID: 7082351
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of chronic monoamine oxidase inhibitor treatment on biogenic amine metabolism in rat brain.
    Robinson DS, Campbell IC, Walker M, Statham NJ, Lovenberg W, Murphy DL.
    Neuropharmacology; 1979 Oct 01; 18(10):771-6. PubMed ID: 42024
    [No Abstract] [Full Text] [Related]

  • 14. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1995 Feb 01; 114(4):837-45. PubMed ID: 7773544
    [Abstract] [Full Text] [Related]

  • 15. Comparison of neurochemical effects of the monoamine oxidase inhibitors phenelzine, moclobemide and brofaromine in the rat after short- and long-term administration.
    Urichuk LJ, Allison K, Holt A, Greenshaw AJ, Baker GB.
    J Affect Disord; 2000 May 01; 58(2):135-44. PubMed ID: 10781703
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine.
    Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S.
    Chem Biol Interact; 2019 May 01; 304():139-147. PubMed ID: 30857888
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin.
    Todd KG, Baker GB.
    J Pharm Pharm Sci; 2008 May 16; 11(2):14s-21s. PubMed ID: 19203467
    [Abstract] [Full Text] [Related]

  • 19. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP, Steinberg R, Leclercq J, Worms P, Biziere K.
    J Neurochem; 1988 Apr 16; 50(4):1137-44. PubMed ID: 3346672
    [Abstract] [Full Text] [Related]

  • 20. Enzymatic N-methylation of phenelzine catalyzed by methyltransferases from adrenal and other tissues.
    Yu PH, Davis BA, Durden DA.
    Drug Metab Dispos; 1991 Apr 16; 19(4):830-4. PubMed ID: 1680662
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.